Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Understanding when to shift from stocks to bonds can enhance your investment strategy. Make informed decisions to maximize returns.
22,202 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Markets opened lower as geopolitical tensions with Iran intensified, sending risk assets lower while energy and defen...
February brought a sharp move in Hycroft Mining stock as gold and silver prices rose and investors weighed future pro...
Oracle leads data center stocks this week as AI cloud momentum outpaces rivals CoreWeave and Applied Digital in a vol...
A high-yield dividend stock jumped about 31% over three months. As March begins, investors must weigh income potentia...
The S&P 500 has fallen 2.5% this month, but Gabelli Multimedia Trust and Trinity Capital have held steady. Their inco...
Warren Buffett's Berkshire Hathaway shows the power of patient capital and simple, durable franchises. This article b...
Oil prices rebounded today, lifting energy stocks. ExxonMobil led gains as the market priced in stronger cash flow, s...
Occidental Petroleum leads the 2026 performance among three top U.S. energy explorers, with EOG Resources and ConocoP...
Palantir has wowed investors with AI-enabled results, but its sky-high valuation raises questions. This guide uses hi...
Cisco surprised investors with strong quarterly results and higher guidance, boosting its stock and signaling robust ...
SpaceX rumors spark a rally in the Procure Space ETF, with the fund tracking the space economy as investors eye a pot...